Skip to main content
. 2022 Jun 29;100(8):1111–1123. doi: 10.1007/s00109-022-02227-x

Fig. 1.

Fig. 1

Genetic changes and epigenetic reprogramming during development underlie the dosage compensation in female and male cells, contributing to sex-biased disease (3.1) manifestation and progression